Patients are often the last to know that a drug has been recalled or that the products may have dangerous side effects, especially when taken with other drugs, a study published Thursday shows.
Dr. Gordon Schiff and his colleagues at Cook County Hospital in Chicago found that some patients kept taking the cholesterol-lowering drug Baycol (cerivastatin) for weeks after it had been recalled and that many were prescribed another cholesterol-cutter, gemfibrozil, despite repeated warnings about its potential to increase the risk of a muscle-wasting condition called rhabdomyolysis.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!